Description

Flecainid SAN (flecainide acetate) tablets 100 mg. №30

Ingredients

Active ingredient: Flecainide acetate. Inactive ingredients may include lactose, magnesium stearate, microcrystalline cellulose, and colloidal silicon dioxide.

Dosage

Dosage: The usual adult dose is 100 mg every 12 hours. Dosage may vary based on individual response and medical condition.

Indications

Indications: Flecainid SAN is indicated for the treatment of certain types of irregular heartbeats (arrhythmias).

Contraindications

Contraindications: Do not use Flecainid SAN if you have certain heart conditions, such as heart block or a slow heartbeat, without consulting a healthcare provider.

Directions

Directions: Take Flecainid SAN exactly as prescribed by your doctor. Swallow the tablets whole with a full glass of water. Do not crush or chew the tablets.

Scientific Evidence

Flecainide acetate is a class Ic antiarrhythmic agent that works by slowing electrical signals in the heart to stabilize irregular heart rhythms. Studies have shown that flecainide is effective in treating various types of arrhythmias, including atrial fibrillation and ventricular tachycardia. Research published in the “Journal of the American College of Cardiology” has demonstrated the efficacy of flecainide in maintaining normal heart rhythm in patients with atrial fibrillation.

Additional Information

It is important to follow your healthcare provider’s instructions carefully while taking Flecainid SAN. Regular monitoring of heart function and electrolyte levels may be necessary during treatment. Inform your doctor about any other medications or supplements you are taking to avoid potential drug interactions.

Pharmacological Effects and Clinical Trials

Flecainide acetate exerts its pharmacological effects by blocking sodium channels in cardiac tissues, which helps in regulating the electrical activity of the heart. Clinical trials have shown that flecainide is effective in reducing the frequency and severity of arrhythmias, improving quality of life in patients with certain cardiac conditions. A study published in the “European Heart Journal” demonstrated the superior efficacy of flecainide compared to placebo in maintaining sinus rhythm in patients with atrial fibrillation.

Overall, Flecainid SAN (flecainide acetate) tablets 100 mg. №30 have shown promising results in the management of arrhythmias, backed by scientific evidence and clinical trials.